Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Borentain

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Clinics and Research in Hepatology and Gastroenterology|January 28, 2014
Liver transplantation for acute liver failure related to autochthonous genotype 3 hepatitis E virus infectionSarah Aherfi, Patrick Borentain, Ferdaous Raissouni, et al.
Annals of Internal Medicine|February 1, 2021
The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt : A Randomized Controlled TrialChristophe Bureau, Dominique Thabut, Caroline Jezequel, et al.
Journal of Medical Virology|July 24, 2014
Hepatitis C virus NS3 protease genotyping and drug concentration determination during triple therapy with telaprevir or boceprevir for chronic infection with genotype 1 viruses, southeastern FranceSarah Aherfi, Caroline Solas, Anne Motte, et al.
Journal of Hepatology|February 1, 2014
Covered vs. uncovered stents for transjugular intrahepatic portosystemic shunt: a randomized controlled trialJean Marc Perarnau, Amélie Le Gouge, Charlotte Nicolas, et al.
Gut Microbes Reports|May 4, 2026
<i>In vitro</i> study of ethanol production, ethanol tolerance, and antimicrobial susceptibility of gut microbes associated with liver diseasesAnissa Idrissa Abdoulaye, Babacar Mbaye, Reham Magdy Wasfy, et al.
Hepatology (Baltimore, Md.)|December 21, 2016
Long-term outcome in liver transplantation candidates with portopulmonary hypertensionLaurent Savale, Caroline Sattler, Audrey Coilly, et al.
The Lancet. Gastroenterology & Hepatology|June 15, 2025
Pre-emptive TIPS for gastric variceal bleeding in patients with cirrhosis (GAVAPROSEC): an open-label randomised clinical trialJean-Paul Cervoni, Delphine Weil, Maxime Desmarets, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Clinics and Research in Hepatology and Gastroenterology|January 28, 2014
Liver transplantation for acute liver failure related to autochthonous genotype 3 hepatitis E virus infectionSarah Aherfi, Patrick Borentain, Ferdaous Raissouni, et al.
Annals of Internal Medicine|February 1, 2021
The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt : A Randomized Controlled TrialChristophe Bureau, Dominique Thabut, Caroline Jezequel, et al.
Journal of Medical Virology|July 24, 2014
Hepatitis C virus NS3 protease genotyping and drug concentration determination during triple therapy with telaprevir or boceprevir for chronic infection with genotype 1 viruses, southeastern FranceSarah Aherfi, Caroline Solas, Anne Motte, et al.
Journal of Hepatology|February 1, 2014
Covered vs. uncovered stents for transjugular intrahepatic portosystemic shunt: a randomized controlled trialJean Marc Perarnau, Amélie Le Gouge, Charlotte Nicolas, et al.
Gut Microbes Reports|May 4, 2026
<i>In vitro</i> study of ethanol production, ethanol tolerance, and antimicrobial susceptibility of gut microbes associated with liver diseasesAnissa Idrissa Abdoulaye, Babacar Mbaye, Reham Magdy Wasfy, et al.
Hepatology (Baltimore, Md.)|December 21, 2016
Long-term outcome in liver transplantation candidates with portopulmonary hypertensionLaurent Savale, Caroline Sattler, Audrey Coilly, et al.
The Lancet. Gastroenterology & Hepatology|June 15, 2025
Pre-emptive TIPS for gastric variceal bleeding in patients with cirrhosis (GAVAPROSEC): an open-label randomised clinical trialJean-Paul Cervoni, Delphine Weil, Maxime Desmarets, et al.
Pageof 7